Literature DB >> 8540757

Vertebrate brains contain a broadly active antiviral substance.

I P Singh1, A K Chopra, D H Coppenhaver, E Smith, J Poast, S Baron.   

Abstract

Brain tissue extracts from vertebrates were examined for non-specific, broad-spectrum virus inhibitors, previously identified and characterized from other body tissues and fluids. An antiviral activity found in human, bovine, ovine, porcine, lapine, murine and piscine brain tissues shares some properties with a contact blocking-virus inhibitor, which was previously found only in cell culture supernatants. The inhibitor was active against (in order of sensitivity to inhibitor) Banzi, Sindbis, Bunyamwera, Newcastle disease, herpes simplex I, Semliki forest, polio I, mengo, vaccinia and vesicular stomatitis viruses. It is approximately 4000 kDa and possesses a complex structure containing protein, carbohydrate and lipid moieties. The inhibitor does not directly neutralize virus or induce an antiviral state in cells, but appears to act early in the replication cycle, most likely by preventing virus attachment to target cells. Its occurrence in concentrations sufficient to reduce virus yield in cell cultures at least 30-fold may indicate a role in limiting viral infections of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540757     DOI: 10.1016/0166-3542(95)00021-d

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  3 in total

1.  Innate gastrointestinal immunity: characterization of broadly active viral inhibitors.

Authors:  I P Singh; D H Coppenhaver; A K Chopra; S Baron
Journal:  Antiviral Res       Date:  2001-03       Impact factor: 5.970

Review 2.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

Review 3.  Innate defences against viraemia.

Authors:  I P Singh; S Baron
Journal:  Rev Med Virol       Date:  2000 Nov-Dec       Impact factor: 6.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.